265 Watline Avenue
Mississauga, ON L4Z 1P3
Canada
https://microbix.com
Sector(s): Healthcare
Industry: Biotechnology
Full Time Employees:
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Mr. Cameron L. Groome | Pres, CEO & Director | 517.44k | N/A | N/A |
Mr. James S. Currie | Chief Financial Officer | 253.56k | N/A | N/A |
Dr. Kenneth Hughes Ph.D. | Chief Operating Officer | 245.89k | N/A | N/A |
Dr. Mark Luscher Ph.D. | Sr. VP of Scientific Affairs | 209.26k | N/A | N/A |
Mr. Philip Casselli | Sr. VP of Sales, Bus. Devel. & Marketing | 233.3k | N/A | N/A |
Mr. Christopher B. Lobb | Compliance Officer, Gen. Counsel & Sec. | N/A | N/A | N/A |
Microbix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. It manufactures a range of critical biological materials for the diagnostics industry, notably test ingredients for immunoassays and quality assessment and proficiency testing controls (QAPs) that support sample collection devices. The company also applies its biological expertise and infrastructure to develop other proprietary products, primarily viral transport medium (DxTM) to test for pathogens and Kinlytic Urokinase, a biologic thrombolytic drug used to treat blood clots. Microbix Biosystems Inc. was founded in 1988 and is based in Mississauga, Canada.
Microbix Biosystems Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.